Condition

Chemotherapy Induced Neuropathic Pain

ClinicalTrials.gov condition label

Clinical trials2

Recruiting0

Common interventions4

Lead sponsors shown2

Clinical trials

2 shown

Efficacy and Safety Study of Halneuron in the Treatment of Chemotherapy-Induced Neuropathic PainNCT06848348 · 2025-02-21

ACTIVE_NOT_RECRUITING

Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NePNCT00407511 · 2007-01-01

COMPLETED

Common interventions

HalneuronDRUG1 Halneuron (Open Label Extension)DRUG1 PlaceboDRUG1 PregabalinDRUG1

Leading sponsors

Dogwood Therapeutics Inc.1 Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1

Trial status mix

ACTIVE_NOT_RECRUITING1

COMPLETED1

Phase mix

PHASE21

PHASE41

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.